Patients with advanced heart failure (AdHF) have a reduced quality of life and poor prognosis. A heart transplant (HT) is an effective treatment for such patients. Still, because of a shortage of donor organs, the final decision to place a patient without contraindications on the HT waiting ...
Transplant and mechanical circulatory support in patients with adult congenital heart disease Advances in surgery and pediatric care over the past decades have achieved improved survival for children born with congenital heart disease (CHD) and have... J Monaco,A Khanna,P Khazanie - 《Heart Failure...
Association of Transplant Center Status With Bridge-to-Transplant Listing Strategy View LargeDownload Table 3. Results of Multivariable Cause-Specific Cox Proportional Hazards Regression Model for Transplant in the 2 Years Following LVAD View LargeDownload Supplement 1. eTable 1. Candidate Risk Factors ...
A heart-lung transplant is performed for unsalvagable dual cardiac and pulmonary failure. An organ transplant is an established life-saving therapy for these patients. The most common underlying conditions requiring heart-lung transplants are congenital cardiac diseases with Eisenmenger syndrome and certa...
(LVAD) or those listed for a heart transplant or LVAD implantation; patients with (cardio-)renal failure requiring frequent fluid status optimisation by means of forced diuresis or dialysis and patients with pulmonary hypertension [44]. An important and often forgotten group of patients are those ...
The secondary efficacy end point was the number of days the patient was alive, out of the hospital, and free from any of the following outcomes: listing for cardiac transplant, cardiac transplant, implantation of a left ventricular assist device, receipt of continuous inotropic therapy for 7 or...
Maintenance or measurement of B2M serum levels in heart transplant patients was suggested as helpful in managing long-term immunosuppressive therapy (Erez et al., 1998. J Heart Lung Transplant 17:538-541). PCT Publication WO 2009/003142 disclose that B2M, along with another protein may be useful...
Fontan-associated protein-losing enteropathy and post–heart transplant outcomes: a multicenter study J Heart Lung Transplant, 38 (2019), pp. 17-25 View in ScopusGoogle Scholar 43 D. Bernstein, D. Naftel, C. Chin, et al. Outcome of listing for cardiac transplantation for failed Fontan: a ...
In the current study, a rat model of heterotopic heart transplantation was established, and the post-transplantation heart can be considered as a tissue with ejection function alone. Therefore, the impact of liver metabolism on endogenous metabolites may be excluded relative to liver transplant models...
Patients were excluded if they had an acute coronary syndrome or revascularization procedure within the prior 30 days, cardiac resynchronization therapy within the prior 3 months, end-stage renal disease, or anticipated heart transplant or mechanical cardiac support within the next 12 months. In ...